Literature DB >> 32647929

Surgical management of thymic epithelial tumors.

Yasushi Shintani1, Soichiro Funaki2, Naoko Ose2, Takashi Kanou2, Eriko Fukui2, Kenji Kimura2, Masato Minami2.   

Abstract

Resection is the mainstay of treatment for thymic epithelial tumors (TETs), with complete removal of the tumor and involved organs being the ultimate aim. The choice of surgical approach plays a major role in defining treatment success, and the optimal choice of method should thus provide an adequate surgical view to achieve complete tumor resection. While median sternotomy is considered the gold standard for access to the mediastinum, several minimally invasive approaches to thymectomy have been described, including video-assisted robotic-assisted thymectomy, although the oncological outcomes of that procedure remain unclear. A multimodal approach incorporating chemotherapy or chemoradiotherapy followed by extended surgery may improve resectability and outcomes for patients with advanced TETs. Surgical debulking is also reportedly acceptable for invasive thymoma because of its potential for achieving favorable outcomes. Re-resection is an acceptable option for patients with recurrent thymoma after initial resection, and repeat resection for recurrent pleural dissemination seems effective. Here, the literature on current clinical practices in the surgical management and treatment of TETs is reviewed.

Entities:  

Keywords:  Adjuvant therapy; Approach; Surgery; Thymic malignancy

Mesh:

Year:  2020        PMID: 32647929     DOI: 10.1007/s00595-020-02070-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  85 in total

Review 1.  The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes.

Authors:  Alexander Marx; John K C Chan; Jean-Michel Coindre; Frank Detterbeck; Nicolas Girard; Nancy L Harris; Elaine S Jaffe; Michael O Kurrer; Edith M Marom; Andre L Moreira; Kiyoshi Mukai; Attilio Orazi; Philipp Ströbel
Journal:  J Thorac Oncol       Date:  2015-10       Impact factor: 15.609

Review 2.  Management of thymic tumors: a European perspective.

Authors:  Enrico Ruffini; Federico Venuta
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

3.  The IASLC/ITMIG thymic malignancies staging project: development of a stage classification for thymic malignancies.

Authors:  Frank C Detterbeck; Hisao Asamura; John Crowley; Conrad Falkson; Giuseppe Giaccone; Dori Giroux; James Huang; Jhingook Kim; Kazuya Kondo; Marco Lucchi; Mirella Marino; Edith M Marom; Andrew Nicholson; Meinoshin Okumura; Enrico Ruffini; Paul van Schil; Kelly Stratton
Journal:  J Thorac Oncol       Date:  2013-12       Impact factor: 15.609

4.  Thymoma with pure red cell aplasia and Good's syndrome.

Authors:  Jun Chen; Yongbo Yang; Daxing Zhu; Gang Chen; Sen Wei; Xiaoming Qiu; Qinghua Zhou
Journal:  Ann Thorac Surg       Date:  2011-05       Impact factor: 4.330

Review 5.  Thymoma associated with autoimmune diseases: 85 cases and literature review.

Authors:  C Bernard; H Frih; F Pasquet; S Kerever; Y Jamilloux; F Tronc; B Guibert; S Isaac; M Devouassoux; L Chalabreysse; C Broussolle; P Petiot; N Girard; P Sève
Journal:  Autoimmun Rev       Date:  2015-09-25       Impact factor: 9.754

6.  Follow-up study of thymomas with special reference to their clinical stages.

Authors:  A Masaoka; Y Monden; K Nakahara; T Tanioka
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

Review 7.  Therapy for thymic epithelial tumors.

Authors:  Kazuya Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-06-10

Review 8.  The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.

Authors:  Francoise Galateau-Salle; Andrew Churg; Victor Roggli; William D Travis
Journal:  J Thorac Oncol       Date:  2016-02       Impact factor: 15.609

9.  Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center.

Authors:  Ioannis Christakis; Wei Qiu; Angelica M Silva Figueroa; Samuel Hyde; Gilbert J Cote; Naifa L Busaidy; Michelle Williams; Elizabeth Grubbs; Jeffrey E Lee; Nancy D Perrier
Journal:  Horm Cancer       Date:  2016-06-16       Impact factor: 3.869

10.  The impact of thymoma histotype on prognosis in a worldwide database.

Authors:  Cleo-Aron Weis; Xiaopan Yao; Yanhong Deng; Frank C Detterbeck; Mirella Marino; Andrew G Nicholson; James Huang; Philipp Ströbel; Alberto Antonicelli; Alexander Marx
Journal:  J Thorac Oncol       Date:  2015-02       Impact factor: 20.121

View more
  3 in total

1.  Surgical feasibility and long-term outcome of superior vena cava replacement for advanced thymoma in patients undergoing preoperative chemotherapy or chemoradiotherapy.

Authors:  Zhen Yu; Lei Yu; Tao Yu; Xing-Guo Yang; Bao-Xun Zhang; Xin Du
Journal:  Thorac Cancer       Date:  2021-02-10       Impact factor: 3.500

2.  Robot-assisted thoracic surgery versus video-assisted thoracic surgery for treatment of patients with thymoma: A systematic review and meta-analysis.

Authors:  Cheng Shen; Jialong Li; Jue Li; Guowei Che
Journal:  Thorac Cancer       Date:  2021-11-22       Impact factor: 3.500

3.  Two types of immune infiltrating cells and six hub genes can predict the occurrence of myasthenia gravis in patients with thymoma.

Authors:  Ziyou Tao; Chao Lu; Shuai Gao; Peng Zhang; Yuan Chen; Yuanguo Wang; Zhaoyu Yang; Kai Xiong; Yuxin Liu; Peng Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.